/Companies

IonPath

4 known investors

Find your way into IonPath

Sign up to find every way you can get introduced to IonPath

  • Your email: who you already know at IonPath, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the IonPath team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.

Investors · 4

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does IonPath do?
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
Who are IonPath's investors?
IonPath's investors include Hemisphere Ventures LLC, Norwich Ventures, Vertical Venture Partners, Samsara BioCapital.